StockData

Mosaic ImmunoEngineering Inc. (CPMV) stock

CPMVOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.33+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.41MP/E –Yield –

Mosaic ImmunoEngineering market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Mosaic ImmunoEngineering's market cap was $2.41M on Oct 19, 2026, against $6.07M a year earlier. Over the last 5 years it ranged from $434.53K to $401.39M, with a median of $5.62M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$2.41M+7.1%
2025Dec 31, 2025$2.25M-55.6%
2024Dec 31, 2024$5.08M+16.9%
2023Dec 29, 2023$4.35M-39.4%
2022Dec 30, 2022$7.17M-98.2%
2020Jun 30, 2020$401.39M0.0%
2019Dec 31, 2019$401.39M-50.0%
2018Dec 31, 2018$802.79M-20.0%
2017Dec 29, 2017$1.00B+25.0%
2016Dec 30, 2016$802.79M-50.0%
2015Dec 31, 2015$1.61B-73.3%
2014Dec 31, 2014$6.02B-70.3%
2013Dec 31, 2013$20.26B–

More Mosaic ImmunoEngineering figures

See a number that looks wrong?